crezacin: a 1:1 mixture of 2-methylphenoxyacetic acid and triethanolamine [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 124292 |
| MeSH ID | M0136942 |
| Synonym |
|---|
| crezacin |
| tris(2-hydroxyethyl)ammonium o-tolyloxyacetate |
| vdps |
| cresacin |
| tris-(2-hydroxyaethyl)-ammonium-ortho-kresoxyazetat [german] |
| t 2m |
| irkutin |
| AKOS003290593 |
| trecrezan |
| tris-(2-hydroxyaethyl)-ammonium-ortho-kresoxyazetat |
| 55543-68-5 |
| krezatsin |
| crezacine |
| tris(2-hydroxyethyl)ammonium-ortho-cresoxy acetate |
| trekrezan |
| DTXSID40204106 |
| 2-[bis(2-hydroxyethyl)amino]ethanol;2-(2-methylphenoxy)acetic acid |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 5 (50.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (11.78) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 1 (4.76%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 20 (95.24%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||